PedAM
Pediatric Disease Annotations & Medicines
| Disease | amyloidosis |
| Phenotype | C0152025|polyneuropathy |
| Sentences | 9 |
| PubMedID- 22277512 | Similar clinical recovery was seen in primary systemic al amyloidosis patients with polyneuropathy after high dose melphalan with auto-pbsct. |
| PubMedID- 22620968 | Regional difference and similarity of familial amyloidosis with polyneuropathy in france. |
| PubMedID- 26096568 | Purpose: assessment of ocular involvement in transthyretin-related familial amyloidosis with polyneuropathy (fap) in a large cohort of portuguese patients. |
| PubMedID- 25743445 | polyneuropathy associated with ttr amyloidosis is typically characterized by small fiber, sensory-motor neuropathy involving symptoms such as pain, sensory loss, numbness, and motor deficits, including walking difficulties [2]. |
| PubMedID- 25416603 | In ttr-familial amyloidosis with polyneuropathy, major changes have occurred over the last 30 years: better knowledge concerning genetics, phenotypes and epidemiology, and the advent of possible treatments. |
| PubMedID- 20840742 | Background: familial amyloidosis with polyneuropathy (fap) is an autosomal dominant disease caused by transthyretin (ttr) mutations, of which v30m (ttr c.148g > a, p.val50met, "val30met") is the most common. |
| PubMedID- 22856884 | Purpose: familial amyloidosis with polyneuropathy (fap) sometimes courses with vitreous amyloid. |
| PubMedID- 22928869 | Familial amyloidosis with polyneuropathy associated with ttr ser50arg mutation. |
| PubMedID- 22941262 | Varied clinical presentations are described in transthyretin (ttr)-familial amyloidosis with polyneuropathy (fap) and light chain amyloid neuropathy. |
Page: 1